Work

The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial

Year: 2019

Type: review

Source: Trends in Pharmacological Sciences

DOI: 10.1016/j.tips.2019.09.008

Authors: Peter John, Yao Wei, Weifeng Liu, Meirong Du, Fangxia Guan, Xingxing Zang

Institutions: Albert Einstein College of Medicine, Shanghai Medical College of Fudan University, Fudan University, Obstetrics and Gynecology Hospital of Fudan University, Zhengzhou University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research Institute, Monique Weill-Caulier Trust, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Mechanisms and Therapies of B7x and B7-H3 in T1D, B7x in Cancer: Mechanisms and Therapies, The B7x pathways in the tumor microenvironment

OpenAlex ID: W2983436315

FWCI: 0.785

Cites: 74

Cited by: 71

Related to: 10